Related Experiment Video
Updated: May 8, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage
Benjamin E Deverman1, Brian L Cook, Scott R Manson
1Division of Urology, Department of Cell Biology and Physiology, School of Medicine, Washington University, 660 South Euclid Avenue, Campus Box 8052, Saint Louis, MO 63110, USA.
Abstract:
The therapeutic value of DNA-damaging antineoplastic agents is dependent upon their ability to induce tumor cell apoptosis while sparing most normal tissues. Here, we show that a component of the apoptotic response to these agents in several different types of tumor cells is the deamidation of two asparagines in the unstructured loop of Bcl-xL, and we demonstrate that deamidation of these asparagines imports susceptibility to apoptosis by disrupting the ability of Bcl-xL to block the proapoptotic activity of BH3 domain-only proteins. Conversely, Bcl-xL deamidation is actively suppressed in fibroblasts, and suppression of deamidation is an essential component of their resistance to DNA damage-induced apoptosis. Our results suggest that the regulation of Bcl-xL deamidation has a critical role in the tumor-specific activity of DNA-damaging antineoplastic agents.
Insights
DNA-damaging cancer drugs trigger apoptosis by deamidating Bcl-xL in tumor cells, but not normal cells. This deamidation makes tumor cells susceptible to apoptosis, highlighting a key mechanism in cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- Therapeutic efficacy of DNA-damaging antineoplastic agents relies on selective tumor cell apoptosis.
- Understanding mechanisms of differential apoptosis induction is crucial for cancer therapy.
Purpose of the Study:
- To investigate the role of Bcl-xL deamidation in the differential apoptotic response to DNA-damaging agents.
- To elucidate the mechanism by which Bcl-xL deamidation affects apoptosis susceptibility.
Main Methods:
- Analysis of Bcl-xL deamidation in various tumor cell lines and fibroblasts.
- Assessment of apoptosis induction following DNA damage.
- Investigation of the interaction between Bcl-xL and BH3 domain-only proteins.
Main Results:
- Deamidation of two asparagines in Bcl-xL's unstructured loop was identified as a key apoptotic response in tumor cells.
- Bcl-xL deamidation disrupts its function, increasing susceptibility to apoptosis by impairing inhibition of proapoptotic BH3 proteins.
- Fibroblasts actively suppress Bcl-xL deamidation, contributing to their resistance to DNA damage-induced apoptosis.
Conclusions:
- Regulation of Bcl-xL deamidation is critical for the tumor-specific effects of DNA-damaging antineoplastic agents.
- Targeting Bcl-xL deamidation pathways may offer novel strategies for enhancing cancer therapy.
Related Concept Videos
Overview of DNA Repair
Chemically...
Base Excision Repair
The first step of...
Fixing Double-strand Breaks
DNA Damage can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
DNA Damage Can Stall the Cell Cycle

